HCPCS code J7699 – Not otherwise classified inhalation solution

Key takeaways

HCPCS code J7699 covers inhalation solutions with no assigned specific HCPCS J-code, not every nebulizer drug.

A compounded drug still takes its specific code when one exists, such as J7610 for compounded concentrated albuterol.

A pharmacy or manufacturer invoice is required documentation every time J7699 is submitted.

Claims route to the DME MAC for the patient’s state, not the local Medicare Administrative Contractor.

The DME MAC prices J7699 from the invoice, because NOC codes carry no national fee schedule rate.

HCPCS code J7699: Definition and official descriptor

HCPCS code J7699 is defined by the Centers for Medicare and Medicaid Services (CMS) as “Noc drugs, inhalation solution administered through DME.” It is the not otherwise classified (NOC) code that closes the J7600-J7699 inhalation solution range.

Coders use it when a prescriber orders a nebulized drug that has no designated J-code of its own. The documentation must also support medical necessity for inhalation therapy.

The J7600-J7699 range is the section of Level II HCPCS reserved for inhalation solutions, and most named drugs in it have specific codes. Albuterol has J7611 and J7613, ipratropium has J7644, and levalbuterol has J7612 and J7614. J7699 covers the inhalation drugs that fall outside those named assignments.

CMS updates the HCPCS Level II code file quarterly, and J7699 has stayed the inhalation NOC code across those update cycles.

What drugs are billed under J7699?

J7699 covers nebulized inhalation drugs that have no specific HCPCS J-code assigned. The most common case is a compounded inhalation solution, mixed by a compounding pharmacy to a custom concentration, formulation or combination. It qualifies only when no code describes that compounded ingredient and form.

J7699 also applies in three other situations:

• Investigational inhalation drugs used under an investigational new drug (IND) authorization
• Newly approved drugs for which CMS has not yet issued a specific J-code
• Drugs whose original code was deleted before a replacement was assigned

In every case, the drug must be given by nebulizer and must have no active specific HCPCS code that applies to it.

What J7699 does not cover

J7699 cannot be used when a specific HCPCS code exists for the drug. Submitting it for albuterol, levalbuterol, ipratropium or another coded drug is a coding error, and payers deny it. Compounding doesn’t change this. If a specific code covers the compounded ingredient, form and route, that code applies.

These are the codes most often confused with J7699, with the concentrated and unit-dose forms billed separately:

• J7611: Albuterol, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per 1 mg. Unit dose bills as J7613.
• J7612: Levalbuterol, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per 0.5 mg. Unit dose bills as J7614.
• J7620: Albuterol, up to 2.5 mg, and ipratropium bromide, up to 0.5 mg, FDA-approved final product, non-compounded, administered through DME
• J7644: Ipratropium bromide, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per mg
• J7609 and J7610: Albuterol, inhalation solution, compounded product, administered through DME, unit dose and concentrated form respectively, per 1 mg

J7699 vs J7611, J7612 and J7620: Choosing the right inhalation code

The choice between J7699 and a specific inhalation code turns on one question. Does a specific HCPCS J-code currently exist for the drug’s ingredient, form and route? If yes, that code is mandatory. If no, J7699 applies, and the decision below shows what each path needs before the claim goes out.

The specific codes also skip the invoice requirement that J7699 carries, as the comparison below sets out code by code.

One frequent error is billing J7699 for a compounded albuterol solution. Albuterol has active compounded codes, J7609 for unit dose and J7610 for concentrated form. J7699 therefore doesn’t apply to a single-ingredient albuterol compound.

Documentation requirements for billing J7699

Durable Medical Equipment Medicare Administrative Contractors (DME MACs) apply stricter documentation standards to NOC codes than to specific J-codes. The payer can’t verify the drug from the code alone. Assemble the complete documentation set before submission, not after a denial.

The physician order or prescription must name the drug, its concentration, the route of administration and the quantity dispensed. It must also carry the diagnosis supporting medical necessity, usually one or more ICD-10-CM codes from the respiratory chapter. DME MAC recordkeeping standards require suppliers to keep this documentation and produce it on request.

• Physician order: Drug name, concentration, route, frequency and quantity dispensed
• Diagnosis: ICD-10-CM code(s) reflecting the condition requiring nebulized therapy
• Invoice: Pharmacy or manufacturer invoice showing drug cost (mandatory for all NOC codes)
• Drug information: If compounded, the compounding pharmacy name, lot number and beyond-use date
• Medical necessity: Chart notes or treatment history showing why this drug is needed when alternatives with specific codes exist

A missing invoice is one of the most common reasons a J7699 claim is denied. NOC codes carry no fee schedule rate, so the DME MAC uses the invoice to set the allowed amount. Without it, the contractor can’t price the claim, and the claim won’t process.

Store pharmacy invoices and prescription records securely under HIPAA, where an auditor can still retrieve them on request.

Prior authorization requirements for J7699

Prior authorization (PA) requirements for HCPCS code J7699 vary by payer and by the DME MAC jurisdiction covering the patient’s state. Original Medicare applies no blanket national PA requirement to J7699. Individual DME MACs may still require prior approval for high-cost NOC drugs, or where the diagnosis code alone doesn’t establish medical necessity.

Commercial payers routinely require PA for NOC inhalation codes. Medicaid policies differ by state, and many state programs require PA for any drug billed under a NOC code. Before submitting a J7699 claim, check the payer’s online authorization portal or call the payer about the specific drug.

When PA is required, the request usually needs five items:

• The drug name and concentration
• The ICD-10-CM diagnosis code
• The physician order
• Clinical notes explaining why a drug with a specific code isn’t appropriate
• The pharmacy invoice showing cost

Turnaround varies by payer, so check the payer’s portal for its timeline. Medicare Advantage plans follow their own PA timelines, which may differ from Original Medicare rules.

Medicare reimbursement for J7699: How claims are processed

J7699 claims for Medicare Part B patients go to the DME MAC for the patient’s state. They don’t go to the local MAC that processes physician and outpatient claims.

There are four DME MAC jurisdictions, served by two contractors: Noridian (Jurisdictions A and D) and CGS Administrators (Jurisdictions B and C). Submitting to the wrong contractor causes routing denials that delay payment.

Unlike specific inhalation drug codes, J7699 has no national rate on the DMEPOS fee schedule. The DME MAC prices J7699 from the invoice and pays 80% of the allowed amount after the Part B deductible. The remaining 20% is the patient’s coinsurance.

Bill J7699 at your usual and customary charge for the drug. Billing below invoice cost loses money on every claim, and billing far above it invites audit scrutiny. A reasonable markup above invoice cost is standard, but it must match the supplier’s customary charge for similar items.

Common J7699 claim denials and how to fix them

Payers can’t confirm the drug’s identity from J7699 alone, so NOC claims get closer review than specific J-codes. Most denials fall into five predictable categories, each with a direct fix. Each denial arrives on the remittance advice with a reason code, explained in our guide to medical billing denial codes.

How to submit a J7699 claim: Step-by-step

A complete J7699 submission follows seven steps in a fixed order. Skipping one is the most direct path to a denial.

1. Confirm no specific code exists: Search the current CMS HCPCS quarterly file or a verified HCPCS code lookup for the drug’s active ingredient. If a specific code exists, use it.
2. Obtain the physician order: Ensure it names the drug, concentration, route, frequency and dispensed quantity, and includes an appropriate ICD-10-CM diagnosis code.
3. Collect the pharmacy or manufacturer invoice: The invoice must reflect the cost of the specific quantity being billed.
4. Confirm PA status: Check whether the payer requires prior authorization for NOC inhalation codes, and obtain it before dispensing if required.
5. Complete the claim form: Report J7699 in the procedure code field. Add the drug name, concentration and quantity in the narrative or supplemental field, as the DME MAC requires. Attach the invoice.
6. Route to the correct DME MAC: Submit to Noridian or CGS based on the patient’s state. Electronic claims use the 837P format, and paper claims use the CMS-1500.
7. Retain documentation: Keep the complete documentation set for at least seven years in case of audit or post-payment review.

ICD-10 diagnosis codes commonly paired with J7699

The ICD-10-CM code on a J7699 claim must reflect a documented condition for which nebulized therapy is medically necessary. The DME MAC’s LCD for nebulizer drugs lists which diagnoses support coverage. COPD flare-ups are among the most frequent pairings, coded as J44.1, but the patient’s documented condition always drives code selection.

Always pair the most specific ICD-10-CM code the documentation supports. An unspecified code, used when a more specific one is documented, can trigger a medical necessity review. Check the selected diagnosis code against the applicable LCD before submitting.

How claims management software keeps J7699 claims moving

Billing J7699 by hand means tracking authorizations, invoices and rejections across separate files and inboxes. A missing piece then surfaces only when the payer sends the claim back.

Pabau, the practice management platform we build, includes claims tools for billers that store each prior authorization as a case. Attach the case at booking, and its authorization code carries through to the claim. A claim missing that code is flagged “Assign case” before it goes out.

US claims go out on the CMS-1500 through Claim.MD, a clearinghouse that reaches thousands of payers and checks eligibility before the visit. A rejected claim is flagged “Needs action,” and the Fix option shows what went wrong and links to the field to correct.

Your billing team corrects and resubmits from one dashboard. It filters claims by insurer or date and tracks each one from Pending to Paid.

Keep NOC drug claims moving to payment

Pabau’s claims management carries each prior authorization onto the claim and flags rejected claims with the field to fix. Your billing team resubmits J7699 claims without rebuilding them.

Book a demo

Conclusion

J7699 rewards the supplier who checks before billing. Confirm that no specific code covers the drug’s ingredient, form and route, including the compounded codes. Then send the order and the invoice with the first submission.

The trade-off is preparation time. A J7699 claim takes longer to build than a specific J-code, but the DME MAC prices it from your invoice. A complete first submission is what gets that price paid without an appeal.

Book a demo to see how Pabau carries prior authorizations onto each claim and flags the rejections your billing team needs to fix.

Continue your research

Need a billing compliance framework for your practice? Medical billing compliance guide covers audit-proofing your claims documentation across code types.

Want to reduce your overall claim denial rate? Denial management in healthcare explains how to build a systematic denial tracking and resolution process.

Billing a non-inhalation drug through DME? HCPCS code J7799 covers the NOC code for other drugs administered through DME.

Looking for broader HCPCS billing context? What is medical billing covers the end-to-end revenue cycle workflow from code selection to payment posting.

Frequently asked questions